Form 4 for IRON Disc Medicine, Inc.
Accepted 2024-03-01 00:00:00 ET · period of report 2024-01-10 · accession 0000950170-24-024187 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-01 | 2024-01-10 | IRON | Savage William Jacob | Chief Medical Off | A - Grant | $0.00 | +18.5K | 21.5K | +618% | $0 |
| D | 2024-03-01 | 2024-01-10 | IRON | Savage William Jacob | Chief Medical Off | A - Grant | $0.00 | +27.8K | 27.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-10 | A | A | 18,535 | $0.00 | 21,535 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-01-10 | A | A | 27,800 | $0.00 | 27,800 | D | $63.90 · — to 2034-01-09 | 27,800 Common Stock | (F1) 25% of the shares underlying this option shall vest and become exercisable on January 10, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date. |